Related references
Note: Only part of the references are listed.Genomic acquisition of a capsular polysaccharide virulence cluster by non- pathogenic Burkholderia isolates
Bernice Meng Qi Sim et al.
GENOME BIOLOGY (2010)
Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei
I-Ching Sam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Infections caused by Gram-positive bacteria: a review of the global challenge
Neil Woodford et al.
JOURNAL OF INFECTION (2009)
Molecular Basis of Rare Aminoglycoside Susceptibility and Pathogenesis of Burkholderia pseudomallei Clinical Isolates from Thailand
Lily A. Trunck et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Melioidosis:: insights into the pathogenicity of Burkholderia pseudomallei
WJ Wiersinga et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
RA Proctor et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
LJV Piddock
CLINICAL MICROBIOLOGY REVIEWS (2006)
Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse
B Maharjan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis
W Chierakul et al.
CLINICAL INFECTIOUS DISEASES (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments
K Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei
MTG Holden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Burkholderia pseudomallei class A β-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition
C Tribuddharat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei
D Godoy et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Characterization of a laboratory-generated variant of BPS β-lactamase from Burkholderia pseudomallei that hydrolyses ceftazidime
PL Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Short report:: A rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia thailandensis
V Wuthiekanun et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis
AWJ Jenney et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Share Paper
